Velo3D Announces Sequential Revenue Growth of 60% / Year over Year Growth of More Than 160% for Second Quarter 2022
Velo3D, Inc. (NYSE: VLD) reported a remarkable 60% revenue increase in Q2 2022, reaching $19.6 million, which is over a 160% year-over-year growth. The company reiterated its FY2022 revenue guidance of $89 million, backed by strong demand and a $55 million backlog. The launch of the Sapphire XC 1MZ system is expected to drive further growth. Despite challenges in gross margins and supply chain issues, Velo3D maintains a strong balance sheet with $142 million in cash.
- Reiterated FY2022 revenue guidance of $89 million, indicating strong performance.
- Booked $18 million in new orders, leading to a $55 million backlog.
- Achieved 60% revenue growth compared to Q1 2022, over 160% year-over-year increase.
- Launched Sapphire XC 1MZ system, the largest in its class with significant demand.
- Gross margin for Q2 2022 was only 6%, reflecting launch pricing and increased costs.
- Supply chain challenges have delayed anticipated cost reductions affecting future gross margins.
- Operating expenses remain high at $27.5 million, despite a slight decline.
Company Reiterates FY2022 Revenue Guidance of
- >15x revenue growth over last 6 quarters – on track to become the largest metal additive manufacturing company, possibly as early as the end of 20221
-
Strong demand - booked
in new orders, backlog of$18 million $55 million -
2022 confidence – 1H22 revenue / backlog account for >
95% of 2022 revenue guidance - Launched new Sapphire XC 1MZ system – largest build volume of any laser PBF printer in its class - initial shipments in Q322
-
Maintained strong balance sheet – exited Q222 with
in cash$142 million
“Our tremendous success in providing our customers with the industry leading additive manufacturing solutions they need is reflected in our revenue growth, increasing more than 15 fold since the first quarter of 2021,” said
“Demand for our industry-leading Sapphire family of systems remains high as we booked
“Looking forward, given our first half execution, strong second quarter bookings, revenue visibility through our backlog and the further scaling of Sapphire XC production, we are very confident in our ability to meet our 2022 revenue guidance of
____________________
1 Company comments and forecasts concerning market share, peer revenue performance and AM industry growth based on data published in the
($ in Millions, except percentages and per-share data) |
2nd Quarter
|
1st Quarter
|
2nd Quarter
|
GAAP revenue |
|
|
|
GAAP gross margin |
|
|
|
GAAP net income (loss)1 |
|
( |
( |
GAAP net income (loss) per diluted share |
|
( |
( |
|
|
|
|
Non-GAAP net loss2 |
( |
( |
( |
Non-GAAP net loss per diluted share2 |
( |
( |
( |
Cash and Investments |
|
|
|
Information about Velo3d’s use of non-GAAP information, including a reconciliation to
1. |
Reconciliations to |
2. | Non-GAAP net loss and non-GAAP net loss per diluted share exclude stock-based compensation expense, and fair value adjustments for the Company’s warrants and earnout liabilities. |
Summary of Second Quarter 2022 results
Revenue for the second quarter was
Gross margin for the quarter was
Operating expenses for the quarter declined slightly to
Net income for the quarter was
The company ended the quarter with a strong balance sheet with
Guidance
For fiscal year 2022, given its strong year to date results and significant backlog, the company is reiterating is previous revenue guidance of
Additional information for fiscal year 2022:
- The company’s business continues to evolve due to new product introductions and changing customer demand trends
-
The company booked
in new orders in the second quarter and has a total backlog of$18 million $55 million -
More than
95% of the company’s 2022 sales forecast is either recognized, booked or expected recurring revenue - Product mix - the company is observing significantly higher average selling prices due to increased Sapphire XC product demand which is expected to offset a lower than forecasted unit count
- End customer mix – the company expects to continue to see a material shift in mix towards higher recurring purchasing rates from existing customer for 2022 than in the initial model
The company will host a conference call for investors this afternoon to discuss its second quarter 2022 performance at
About
VELO,
Amounts herein pertaining to
Forward-Looking Statements:
This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1996. The company’s actual results may differ from its expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect”, “estimate”, “project”, “budget”, “forecast”, “anticipate”, “intend”, “plan”, “may”, “will”, “could”, “should”, “believes”, “predicts”, “potential”, “continue”, and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the company’s guidance for full year 2022 (including the company’s estimates for revenue), the company’s expectations regarding its potential to become the largest company in metal additive manufacturing, its recurring revenue and its pricing, improved production efficiencies and gross margin during 2022, the company’s strategic priorities for 2022 (including the company’s market and customer expansion plans), the company’s expectations regarding its liquidity and capital requirements, and the company’s other expectations, hopes, beliefs, intentions or strategies for the future. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. You should carefully consider the risks and uncertainties described in the “Risk Factors” section of the company’s Annual Report on Form 10-K for the fiscal year ended
Non-GAAP Financial Information
The company uses non-GAAP financial measures to help it make strategic decisions, establish budgets and operational goals for managing its business, analyze its financial results and evaluate its performance. The company also believes that the presentation of these non-GAAP financial measures in this release provides an additional tool for investors to use in comparing the company’s core business and results of operations over multiple periods. However, the non-GAAP financial measures presented in this release may not be comparable to similarly titled measures reported by other companies due to differences in the way that these measures are calculated. The non-GAAP financial measures presented in this release should not be considered as the sole measure of the company’s performance and should not be considered in isolation from, or as a substitute for, comparable financial measures calculated in accordance with generally accepted accounting principles accepted in
The information in the table below sets forth the non-GAAP financial measures that the company uses in this release. Because of the limitations associated with these non-GAAP financial measures, “Non-GAAP Net Loss”, “EBITDA”, “Adjusted EBITDA”, and “Adjusted Operating Expenses”, should not be considered in isolation or as a substitute for performance measures calculated in accordance with GAAP. The company compensates for these limitations by relying primarily on its GAAP results and using Non-GAAP Net Loss, EBITDA, Adjusted EBITDA, and Adjusted Operating Expenses on a supplemental basis. You should review the reconciliation of the non-GAAP financial measures below and not rely on any single financial measure to evaluate the company's business.
The following tables reconcile Net income (loss) to Non-GAAP Net Loss, EBITDA, and Adjusted EBITDA and Total Operating Expenses to Adjusted Operating Expenses during the three months ended
NON-GAAP Net Loss Reconciliation (Unaudited) |
||||||||||||||||||||||||||||||||
|
Three months ended |
|
Six months ended |
|
Three months ended |
|||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
2022 |
2021 |
|
2022 |
2021 |
|
2022 |
2021 |
||||||||||||||||||||||||
|
(In thousands, except share and per share data) |
|
||||||||||||||||||||||||||||||
|
|
% of Rev |
|
% of Rev |
|
|
% of Rev |
|
% of Rev |
|
|
% of Rev |
|
% of Rev |
||||||||||||||||||
Revenues |
$ |
19,644 |
|
100 |
% |
$ |
7,146 |
|
100 |
% |
|
$ |
31,862 |
|
100 |
% |
$ |
8,318 |
|
100 |
% |
|
$ |
12,218 |
|
100 |
% |
$ |
1,172 |
|
100 |
% |
Gross profit |
|
1,232 |
|
6.3 |
% |
|
2,184 |
|
30.6 |
% |
|
|
1,247 |
|
3.9 |
% |
|
1,794 |
|
21.6 |
% |
|
|
15 |
|
0.1 |
% |
|
(390 |
) |
(33.3 |
)% |
Net income (loss) |
$ |
127,950 |
|
651.3 |
% |
$ |
(12,538 |
) |
(175.5 |
)% |
|
$ |
62,608 |
|
196.5 |
% |
$ |
(26,086 |
) |
(313.6 |
)% |
|
$ |
(65,341 |
) |
(534.8 |
)% |
$ |
(13,548 |
) |
(1156.0 |
)% |
Stock-based compensation |
|
4,976 |
|
25.3 |
% |
|
760 |
|
10.6 |
% |
|
|
9,933 |
|
31.2 |
% |
|
1,075 |
|
12.9 |
% |
|
|
4,957 |
|
40.6 |
% |
|
315 |
|
26.9 |
% |
(Gain) loss on fair value of warrants |
|
(23,665 |
) |
(120.5 |
)% |
|
227 |
|
3.2 |
% |
|
|
(17,651 |
) |
(55.4 |
)% |
|
1,741 |
|
20.9 |
% |
|
|
6,014 |
|
49.2 |
% |
|
1,514 |
|
129.2 |
% |
(Gain) loss on fair value of contingent earnout liabilities |
|
(130,227 |
) |
(662.9 |
)% |
|
— |
|
— |
% |
|
|
(98,995 |
) |
(310.7 |
)% |
|
— |
|
— |
% |
|
|
31,232 |
|
255.6 |
% |
|
— |
|
— |
% |
Merger related transactional costs |
|
— |
|
— |
% |
|
1,583 |
|
22.2 |
% |
|
|
— |
|
— |
% |
|
3,514 |
|
42.2 |
% |
|
|
— |
|
— |
% |
|
1,931 |
|
164.8 |
% |
Non-GAAP Net loss |
$ |
(20,966 |
) |
(106.7 |
)% |
$ |
(9,968 |
) |
(139.5 |
% |
|
$ |
(44,105 |
) |
(138.4 |
)% |
$ |
(19,756 |
) |
(237.5 |
)% |
|
$ |
(23,138 |
) |
(189.4 |
)% |
$ |
(9,788 |
) |
(835.2 |
)% |
NON-GAAP Adjusted EBITDA Reconciliation (Unaudited) |
||||||||||||||||||||||||||||||||
|
Three months ended |
|
Six months ended |
|
Three months ended |
|||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
2022 |
2021 |
|
2022 |
2021 |
|
2022 |
2021 |
||||||||||||||||||||||||
|
(In thousands) |
|||||||||||||||||||||||||||||||
|
|
% of Rev |
|
% of Rev |
|
|
% of Rev |
|
% of Rev |
|
|
% of Rev |
|
% of Rev |
||||||||||||||||||
Revenues |
$ |
19,644 |
|
100 |
% |
$ |
7,146 |
|
100 |
% |
|
$ |
31,862 |
|
100 |
% |
$ |
8,318 |
|
100 |
% |
|
$ |
12,218 |
|
100 |
% |
$ |
1,172 |
|
100 |
% |
Net income (loss) |
$ |
127,950 |
|
651.3 |
% |
$ |
(12,538 |
) |
(175.5 |
)% |
|
$ |
62,608 |
|
196.5 |
% |
$ |
(26,086 |
) |
(313.6 |
)% |
|
$ |
(65,341 |
) |
(534.8 |
) % |
$ |
(13,548 |
) |
(1156.0 |
)% |
Interest expense |
|
92 |
|
0.5 |
% |
|
524 |
|
7.3 |
% |
|
|
233 |
|
0.7 |
% |
|
644 |
|
7.7 |
% |
|
|
141 |
|
1.2 |
% |
|
120 |
|
10.2 |
% |
Tax expense |
|
— |
|
— |
% |
|
— |
|
— |
% |
|
|
— |
|
— |
% |
|
— |
|
— |
% |
|
|
— |
|
— |
% |
|
— |
|
— |
% |
Depreciation and amortization |
|
1,087 |
|
5.5 |
% |
|
329 |
|
4.6 |
% |
|
|
2,108 |
|
6.6 |
% |
|
692 |
|
8.3 |
% |
|
|
1,021 |
|
8.4 |
% |
|
363 |
|
31.0 |
% |
EBITDA |
|
129,129 |
|
657.3 |
% |
|
(11,685 |
) |
(163.5 |
)% |
|
|
64,949 |
|
203.8 |
% |
|
(24,750 |
) |
(297.5 |
)% |
|
|
(64,179 |
) |
(525.3 |
)% |
|
(13,065 |
) |
(1114.8 |
)% |
Stock-based compensation |
|
4,976 |
|
25.3 |
% |
|
760 |
|
10.6 |
% |
|
|
9,933 |
|
31.2 |
% |
|
1,075 |
|
12.9 |
% |
|
|
4,957 |
|
40.6 |
% |
|
315 |
|
26.9 |
% |
(Gain) loss on fair value of warrants |
|
(23,665 |
) |
(120.5 |
)% |
|
227 |
|
3.2 |
% |
|
|
(17,651 |
) |
(55.4 |
)% |
|
1,741 |
|
20.9 |
% |
|
|
6,014 |
|
49.2 |
% |
|
1,514 |
|
129.2 |
% |
(Gain) loss on fair value of contingent earnout liabilities |
|
(130,227 |
) |
(662.9 |
)% |
|
— |
|
— |
% |
|
|
(98,995 |
) |
(310.7 |
)% |
|
— |
|
— |
% |
|
|
31,232 |
|
255.6 |
% |
|
— |
|
— |
% |
Adjusted EBITDA |
$ |
(19,787 |
) |
(100.7 |
)% |
$ |
(10,698 |
) |
(149.7 |
)% |
|
$ |
(41,764 |
) |
(131.1 |
)% |
$ |
(21,934 |
) |
(263.7 |
)% |
|
$ |
(21,976 |
) |
(179.9 |
)% |
$ |
(11,236 |
) |
(958.7 |
)% |
Merger related transactional costs |
|
— |
|
— |
% |
|
1,583 |
|
22.2 |
% |
|
|
— |
|
— |
% |
|
3,514 |
|
42.2 |
% |
|
|
— |
|
— |
% |
|
1,931 |
|
164.8 |
% |
Adjusted EBITDA excluding merger related transactional costs |
$ |
(19,787 |
) |
(100.7 |
) % |
$ |
(9,115 |
) |
(127.6 |
)% |
|
$ |
(41,764 |
) |
(131.1 |
)% |
$ |
(18,420 |
) |
(221.4 |
)% |
|
$ |
(21,976 |
) |
(179.9 |
)% |
$ |
(9,305 |
) |
(793.9 |
)% |
NON-GAAP Adjusted Operating Expenses Reconciliation (Unaudited) |
||||||||||||||||||||||||||
|
|
|
|
|
||||||||||||||||||||||
|
Three months ended |
|
Six months ended |
|
Three months ended |
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
2022 |
2021 |
|
2022 |
2021 |
|
2022 |
2021 |
||||||||||||||||||
|
(In thousands) |
|||||||||||||||||||||||||
|
|
% of Rev |
|
% of Rev |
|
|
% of Rev |
|
% of Rev |
|
|
% of Rev |
|
% of Rev |
||||||||||||
Revenues |
$ |
19,644 |
100 |
% |
$ |
7,146 |
100 |
% |
|
$ |
31,862 |
100 |
% |
$ |
8,318 |
100 |
% |
|
$ |
12,218 |
100 |
% |
$ |
1,172 |
100 |
% |
Operating expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Research and development |
|
12,965 |
66.0 |
% |
|
6,399 |
89.5 |
% |
|
|
25,880 |
81.2 |
% |
|
11,094 |
133.4 |
% |
|
|
12,915 |
105.7 |
% |
|
4,695 |
400.6 |
% |
Selling and marketing |
|
6,249 |
31.8 |
% |
|
2,337 |
32.7 |
% |
|
|
12,232 |
38.4 |
% |
|
4,360 |
52.4 |
% |
|
|
5,983 |
49.0 |
% |
|
2,023 |
172.6 |
% |
General and administrative |
|
8,259 |
42.0 |
% |
|
5,218 |
73.0 |
% |
|
|
17,549 |
55.1 |
% |
|
10,004 |
120.3 |
% |
|
|
9,290 |
76.0 |
% |
|
4,786 |
408.4 |
% |
Total operating expenses |
|
27,473 |
139.9 |
% |
|
13,954 |
195.3 |
% |
|
|
55,661 |
174.7 |
% |
|
25,458 |
306.1 |
% |
|
|
28,188 |
230.7 |
% |
|
11,504 |
981.6 |
% |
Stock-based compensation |
|
4,976 |
25.3 |
% |
|
760 |
10.6 |
% |
|
|
9,933 |
31.2 |
% |
|
1,075 |
12.9 |
% |
|
|
4,957 |
40.6 |
% |
|
315 |
26.9 |
% |
Merger related transactional costs |
|
— |
— |
% |
|
1,583 |
22.2 |
% |
|
|
— |
— |
% |
|
3,514 |
42.2 |
% |
|
|
— |
— |
% |
|
1,931 |
164.8 |
% |
Adjusted operating expenses |
$ |
22,497 |
114.5 |
% |
$ |
11,611 |
162.5 |
% |
|
$ |
45,728 |
143.5 |
% |
$ |
20,869 |
250.9 |
% |
|
$ |
23,231 |
190.1 |
% |
$ |
9,258 |
789.9 |
% |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) (In thousands, except share and per share data) |
|||||||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
2022 |
|
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Revenue |
|
|
|
|
|
|
|
|
|
||||||||||
3D Printer |
$ |
17,615 |
|
|
$ |
10,184 |
|
|
$ |
6,079 |
|
|
$ |
27,799 |
|
|
$ |
6,313 |
|
Recurring payment |
|
934 |
|
|
|
925 |
|
|
|
372 |
|
|
|
1,859 |
|
|
|
635 |
|
Support services |
|
1,095 |
|
|
|
1,109 |
|
|
|
695 |
|
|
|
2,204 |
|
|
|
1,370 |
|
Total Revenue |
|
19,644 |
|
|
|
12,218 |
|
|
|
7,146 |
|
|
|
31,862 |
|
|
|
8,318 |
|
Cost of revenue |
|
|
|
|
|
|
|
|
|
||||||||||
3D Printer |
|
15,633 |
|
|
|
10,479 |
|
|
|
3,899 |
|
|
|
26,112 |
|
|
|
4,482 |
|
Recurring payment |
|
685 |
|
|
|
718 |
|
|
|
257 |
|
|
|
1,403 |
|
|
|
444 |
|
Support services |
|
2,094 |
|
|
|
1,006 |
|
|
|
806 |
|
|
|
3,100 |
|
|
|
1,598 |
|
Total cost of revenue |
|
18,412 |
|
|
|
12,203 |
|
|
|
4,962 |
|
|
|
30,615 |
|
|
|
6,524 |
|
Gross profit |
|
1,232 |
|
|
|
15 |
|
|
|
2,184 |
|
|
|
1,247 |
|
|
|
1,794 |
|
Operating expenses |
|
|
|
|
|
|
|
|
|
||||||||||
Research and development |
|
12,965 |
|
|
|
12,915 |
|
|
|
6,399 |
|
|
|
25,880 |
|
|
|
11,094 |
|
Selling and marketing |
|
6,249 |
|
|
|
5,983 |
|
|
|
2,337 |
|
|
|
12,232 |
|
|
|
4,360 |
|
General and administrative |
|
8,259 |
|
|
|
9,290 |
|
|
|
5,218 |
|
|
|
17,549 |
|
|
|
10,004 |
|
Total operating expenses |
|
27,473 |
|
|
|
28,188 |
|
|
|
13,954 |
|
|
|
55,661 |
|
|
|
25,458 |
|
Loss from operations |
|
(26,241 |
) |
|
|
(28,173 |
) |
|
|
(11,770 |
) |
|
|
(54,414 |
) |
|
|
(23,664 |
) |
Interest expense |
|
(92 |
) |
|
|
(141 |
) |
|
|
(524 |
) |
|
|
(233 |
) |
|
|
(644 |
) |
Gain (loss) on fair value of warrants |
|
23,665 |
|
|
|
(6,014 |
) |
|
|
(227 |
) |
|
|
17,651 |
|
|
|
(1,741 |
) |
Gain (loss) on fair value of contingent earnout liabilities |
|
130,227 |
|
|
|
(31,232 |
) |
|
|
— |
|
|
|
98,995 |
|
|
|
— |
|
Other income (expense), net |
|
391 |
|
|
|
219 |
|
|
|
(17 |
) |
|
|
609 |
|
|
|
(37 |
) |
Income (loss) before provision for income taxes |
|
127,950 |
|
|
|
(65,341 |
) |
|
|
(12,538 |
) |
|
|
62,608 |
|
|
|
(26,086 |
) |
Provision for income taxes |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Net income (loss) |
$ |
127,950 |
|
|
$ |
(65,341 |
) |
|
$ |
(12,538 |
) |
|
$ |
62,608 |
|
|
$ |
(26,086 |
) |
|
|
|
|
|
|
|
|
|
|
||||||||||
Net income (loss) per share: |
|
|
|
|
|
|
|
|
|
||||||||||
Basic |
$ |
0.69 |
|
|
$ |
(0.36 |
) |
|
$ |
(0.78 |
) |
|
$ |
0.34 |
|
|
$ |
(1.62 |
) |
Diluted |
$ |
0.63 |
|
|
$ |
(0.36 |
) |
|
$ |
(0.78 |
) |
|
$ |
0.31 |
|
|
$ |
(1.62 |
) |
Shares used in computing net income (loss) per share: |
|
|
|
|
|
|
|
|
|
||||||||||
Basic |
|
184,282,194 |
|
|
|
183,498,082 |
|
|
|
16,150,202 |
|
|
|
183,892,304 |
|
|
|
16,085,750 |
|
Diluted |
|
202,384,512 |
|
|
|
183,498,082 |
|
|
|
16,150,202 |
|
|
|
203,089,266 |
|
|
|
16,085,750 |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net income (loss) |
$ |
127,950 |
|
|
$ |
(65,341 |
) |
|
$ |
(12,538 |
) |
|
$ |
62,608 |
|
|
$ |
(26,086 |
) |
Net unrealized holding loss on available-for-sale investments |
|
(335 |
) |
|
|
(594 |
) |
|
|
— |
|
|
|
(943 |
) |
|
|
— |
|
Other comprehensive income (loss) |
$ |
127,615 |
|
|
$ |
(65,935 |
) |
|
$ |
(12,538 |
) |
|
$ |
61,665 |
|
|
$ |
(26,086 |
) |
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (In thousands, except share and per share data) |
|||||||
|
|
|
|
||||
|
|
2022 |
|
|
|
2021 |
|
Assets |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
43,509 |
|
|
$ |
207,602 |
|
Short-term investments |
|
98,287 |
|
|
|
15,483 |
|
Accounts receivable, net |
|
11,817 |
|
|
|
12,778 |
|
Inventories |
|
61,909 |
|
|
|
22,479 |
|
Contract assets |
|
405 |
|
|
|
274 |
|
Prepaid expenses and other current assets |
|
6,695 |
|
|
|
9,458 |
|
Total current assets |
|
222,622 |
|
|
|
268,074 |
|
Property and equipment, net |
|
17,717 |
|
|
|
10,046 |
|
Equipment on lease, net |
|
8,128 |
|
|
|
8,366 |
|
Other assets |
|
14,948 |
|
|
|
16,231 |
|
Total assets |
$ |
263,415 |
|
|
$ |
302,717 |
|
Liabilities and Stockholders’ Equity |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
15,744 |
|
|
$ |
9,882 |
|
Accrued expenses and other current liabilities |
|
16,485 |
|
|
|
9,414 |
|
Debt – current portion |
|
5,119 |
|
|
|
5,114 |
|
Contract liabilities |
|
16,175 |
|
|
|
22,252 |
|
Total current liabilities |
|
53,523 |
|
|
|
46,662 |
|
Long-term debt – less current portion |
|
1,889 |
|
|
|
2,956 |
|
Contingent earnout liabilities |
|
12,493 |
|
|
|
111,487 |
|
Warrant liabilities |
|
4,053 |
|
|
|
21,705 |
|
Other noncurrent liabilities |
|
8,874 |
|
|
|
9,492 |
|
Total liabilities |
|
80,832 |
|
|
|
192,302 |
|
Commitments and contingencies |
|
|
|
||||
Stockholders’ equity: |
|
|
|
||||
Common stock, |
|
2 |
|
|
|
2 |
|
Additional paid-in capital |
|
350,797 |
|
|
|
340,294 |
|
Accumulated other comprehensive loss |
|
(957 |
) |
|
|
(14 |
) |
Accumulated deficit |
|
(167,259 |
) |
|
|
(229,867 |
) |
Total stockholders’ equity |
|
182,583 |
|
|
|
110,415 |
|
Total liabilities and stockholders’ equity |
$ |
263,415 |
|
|
$ |
302,717 |
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (In thousands) |
|||||||
|
Six Months Ended |
||||||
|
|
|
|
||||
|
|
2022 |
|
|
|
2021 |
|
Cash flows from operating activities |
|
|
|
||||
Net income (loss) |
$ |
62,608 |
|
|
$ |
(26,086 |
) |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities |
|
|
|
||||
Depreciation and amortization |
|
2,108 |
|
|
|
692 |
|
Stock-based compensation |
|
9,933 |
|
|
|
1,075 |
|
(Gain) loss on fair value of warrants |
|
(17,651 |
) |
|
|
1,741 |
|
(Gain) loss on fair value of contingent earnout liabilities |
|
(98,995 |
) |
|
|
— |
|
Changes in assets and liabilities |
|
|
|
||||
Accounts receivable |
|
961 |
|
|
|
(2,648 |
) |
Inventories |
|
(34,826 |
) |
|
|
(1,279 |
) |
Contract assets |
|
(131 |
) |
|
|
2,873 |
|
Prepaid expenses and other current assets |
|
7,049 |
|
|
|
(1,748 |
) |
Other assets |
|
1,283 |
|
|
|
(2,156 |
) |
Accounts payable |
|
(415 |
) |
|
|
5,296 |
|
Accrued expenses and other liabilities |
|
5,977 |
|
|
|
779 |
|
Contract liabilities |
|
(6,077 |
) |
|
|
7,190 |
|
Other noncurrent liabilities |
|
(617 |
) |
|
|
1,249 |
|
Net cash used in operating activities |
|
(68,793 |
) |
|
|
(13,022 |
) |
Cash flows from investing activities |
|
|
|
||||
Purchase of property and equipment |
|
(8,578 |
) |
|
|
(601 |
) |
Production of equipment for lease to customers |
|
(2,563 |
) |
|
|
(5,044 |
) |
Purchases of available-for-sale investments |
|
(87,655 |
) |
|
|
— |
|
Proceeds from maturities of available-for-sale investments |
|
4,000 |
|
|
|
— |
|
Net cash used in investing activities |
|
(94,796 |
) |
|
|
(5,645 |
) |
Cash flows from financing activities |
|
|
|
||||
Proceeds from loan issuance |
|
— |
|
|
|
14,339 |
|
Repayment of term loan |
|
— |
|
|
|
(4,888 |
) |
Proceeds from convertible notes |
|
— |
|
|
|
5,000 |
|
Proceeds from equipment loans |
|
— |
|
|
|
3,200 |
|
Repayment of equipment loans |
|
(1,067 |
) |
|
|
(1,636 |
) |
Issuance of common stock upon exercise of stock options |
|
570 |
|
|
|
283 |
|
Net cash (used in) provided by financing activities |
|
(497 |
) |
|
|
16,298 |
|
Effect of exchange rate changes on cash and cash equivalents |
|
(7 |
) |
|
|
— |
|
Net change in cash and cash equivalents |
|
(164,093 |
) |
|
|
(2,369 |
) |
Cash and cash equivalents and restricted cash at beginning of period |
|
208,402 |
|
|
|
15,517 |
|
Cash and cash equivalents and restricted cash at end of period |
$ |
44,309 |
|
|
$ |
13,148 |
|
|
|
|
|
||||
Supplemental disclosure of cash flow information |
|
|
|
||||
Cash paid for interest |
$ |
152 |
|
|
$ |
280 |
|
Supplemental disclosure of non-cash information |
|
|
|
||||
Issuance of common stock warrants in connection with financing |
$ |
— |
|
|
$ |
134 |
|
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total of such amounts shown on the condensed consolidated statements of cash flows:
|
Six Months Ended |
||||
|
|
|
|
||
|
|
2022 |
|
|
2021 |
|
|
||||
Cash and cash equivalents |
$ |
43,509 |
|
$ |
13,148 |
Restricted cash (Other assets) |
|
800 |
|
|
— |
Total cash and cash equivalents, and restricted cash |
$ |
44,309 |
|
$ |
13,148 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220809005797/en/
Investor Relations:
Bob Okunski, VP Investor Relations
investors@velo3d.com
Media Contact:
dan.sorensen@velo3d.com
Source:
FAQ
What is Velo3D's revenue guidance for FY2022?
How much revenue did Velo3D report for Q2 2022?
What is the significance of the Sapphire XC 1MZ system?
How did Velo3D's revenue grow compared to previous quarters?